Updated October 4 at 12:45am
44 results total, viewing 1 - 10
(Updated, 4 p.m., Aug. 21) Some of the region’s most notable companies have been named in Providence Business News’ fourth Fastest-Growing & Innovative Companies awards program. more
Venture capitalists invested $124.1 million in Rhode Island companies in 2014, $42 million more than in 2013, and the largest amount to date, according to the MoneyTree Report by PricewaterhouseCoopers LLP and the National Venture Capital Association. more
ProThera Biologics has appointed Denice M. Spero as president and chief business officer. more
Nabsys Inc., a life sciences company that was trying to bring its genome-mapping products to market, closed recently, throwing approximately 40 people out of work. more
To Amgen Inc.'s Senior Manager for Manufacturing Jimmy Fleming, the task of ensuring that he and his team are producing a quality product is of the utmost importance – professionally and personally. Fleming's sister is one of the more … more
EpiVax Inc. and Novozymes Biopharma entered into a license agreement for the development of treatments for autoimmune diseases, the companies announced on Monday. more
A Japanese biopharmaceutical company has contracted to begin using a protein-screening interface developed by Providence-based EpiVax Inc. more
(Updated, 5:14 p.m.) A Cherrystone Angel Group portfolio business has entered into an acquisition agreement of $140 million with a European buyer specializing in bio-analytical testing and genomic services. more
Medrobotics Corp. was named a “rising star” in the Smaller Business Association of New England Inc.’s 2015 New England Innovation Awards. more
(Updated, 5:40 p.m.) Ximedica announced Tuesday it has purchased the San Francisco-based Bridge Design, providing the Rhode Island-based medical technology development company with a West Coast hub. more
1 | 2 | 3 | 4 | 5 Next »